COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by slagheapon Aug 14, 2015 2:27pm

202 Views

Post# 24019555

RE:what a disaster

So if I project ahead three months to the next QR in November we get this; The company has US$45m cash. The warrants will bring in $24m to total $69m. The quarterly burn is $15m. So in three months AEZ should have $54m in cash and 300m o/s or $0.18 p/s. When it finally bottoms sometime in the next seven weeks it will be a buy and that`s before the phase 3 results in October.

Bullboard Posts

QNB Metals stock adds 400 per cent after white hydrogen deal